Tiefenbacher Pharmaceuticals successfully prepares the launch of the generic version of Ezetimibe/Atorvastatin across the European Union
We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world – irrespective of their nationality or income. That´s why we are thrilled to share that we have successfully prepared a day one launch of the generic version of Ezetimibe/Atorvastatin in 12 European markets.
Tiefenbacher Pharmaceuticals Ezetimibe/Atorvastatin is a combination therapy that addresses two key factors contributing to high cholesterol levels:
Ezetimibe/Atorvastatin is used to reduce the production of cholesterol in the liver. Furthermore it helps to limit the absorption of cholesterol from the intestines. This dual action approach has the potential to lower LDL cholesterol (“bad” cholesterol), which could offer cardiovascular benefits, particularly for patients at risk of heart disease or stroke. The combination of Atorvastatin and Ezetimibe is a treatment option that is frequently considered by healthcare providers to treat patients with high cholesterol, especially those who are unresponsive to single-agent therapy. By offering this affordable medicine, we are providing a valuable option for those in need. At the same time, we can really make a difference in improving the lives of patients. The tablets are marketed in the strengths of 10mg/10mg, 10mg/20mg, 10mg/40mg, and 10mg/80mg
This launch reflects our ongoing commitment to providing patients with high-quality, cost-effective medications and is a testament to the hard work and commitment of our team
In case of inquiries please reach out to licensing@tiefenbacher.com
TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices and e-health-solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.
For more information about our finished dosage forms (FDF) including highly potent drugs and e-healthcare solutions, please contact us at info@tiefenbacher.com or visit us on www.tiefenbacher-pharmaceuticals.com
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company. We are providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about TIEFENBACHER GROUP please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com
